260TiP - Phase 3, randomized, double-blind, placebo-controlled study of PEGylated recombinant human hyaluronidase PH20 (PEGPH20)+nab-paclitaxel/gemcitabine in patients with previously untreated, hyaluronan-high, stage IV pancreatic ductal adenocarcinoma (PDA)
| Autor: | Oh, D-Y, Bang, Y-J, Van Cutsem, E., Hendifar, A., Reni, M., Zheng, L., Ducreux, M., Harris, W., Corrie, P., Seery, T., Chondros, D., Bullock, A., Li, C-P |
|---|---|
| Zdroj: | In Annals of Oncology November 2017 28 Supplement 10:x75-x76 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|